bis-(1,2-dichloro-ethyl) ether | 7166-44-1

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机氯化物
• 英文名称: bis-(1,2-dichloro-ethyl) ether
• 英文别名: Bis-(1,2-dichlor-aethyl)-aether；1,2,1',2'-Tetrachlor-diethylether；1,2-Dichloroethyl ether；1,2-dichloro-1-(1,2-dichloroethoxy)ethane
• CAS: 7166-44-1
• 化学式: C₄H₆Cl₄O
• 分子量: 211.903
• InChiKey: MRYZFSAURXJWHV-UHFFFAOYSA-N

物化性质

• 沸点：
  66-68 °C(Press: 45 Torr)
• 密度：
  1.457 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  9
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  bis-(1,2-dichloro-ethyl) ether 生成 (2-chloro-vinyl)-(1,2-dichloro-ethyl)-ether
  参考文献：
  名称：

  氯化乙烯基醚的新途径

  摘要：

  DOI：

  10.1021/ie50593a035
• 作为产物：
  描述：

  二氯乙醚 在 氯 作用下， 生成 bis-(1,2-dichloro-ethyl) ether
  参考文献：
  名称：

  氯化乙烯基醚的新途径

  摘要：

  DOI：

  10.1021/ie50593a035

文献信息

• Imidazo-substituted compounds as p38 kinase inhibitors
  申请人：——

  公开号：US20030232847A1

  公开（公告）日：2003-12-18

  The present invention discloses compounds corresponding to formula I: 1 wherein A, Z, Z 1 , Y, R 1 and R 2 are as defined in the specification, as well as pharmaceutical formulations, methods of making and uses thereof.

  本发明公开了与下式I:1相对应的化合物：其中A、Z、Z1、Y、R1和R2如规范中定义的那样，以及药物配方、制备方法和用途。
• Biphenyl and biphenyl-analogous compounds as integrin antagonists
  申请人：——

  公开号：US20020016461A1

  公开（公告）日：2002-02-07

  The present invention relates to biphenyl and biphenyl-analogous compounds, their preparation and use as pharmaceutical compositions, as integrin antagonists and in particular for the production of pharmaceutical compositions for the treatment and prophylaxis of cancer, arteriosclerosis, restenosis, osteolytic disorders such as osteoporosis and ophthalmic diseases. The compounds according to the invention have the formula ( 1 ) 1 wherein R 1 , R 2 , U, V, A, B, W, R 3 , C and R 4 have the meaning as defined in the claims.

  本发明涉及联苯和类联苯化合物，它们的制备和用作药物组合物，作为整合素拮抗剂，特别用于生产用于治疗和预防癌症、动脉硬化、再狭窄、骨溶解性疾病如骨质疏松和眼科疾病的药物组合物。根据本发明的化合物具有以下式(1)其中R1、R2、U、V、A、B、W、R3、C和R4的含义如权利要求中所定义。
• New biphenyl and biphenyl-analogous compounds as integrin antagonists
  申请人：——

  公开号：US20040030132A1

  公开（公告）日：2004-02-12

  The present invention relates to biphenyl and biphenyl-analogous compounds, their preparation and use as pharmaceutical compositions, as integrin antagonists and in particular for the production of pharmaceutical compositions for the treatment and prophylaxis of cancer, arteriosclerosis, restenosis, osteolytic disorders such as osteoporosis and ophthalmic diseases. The compounds according to the invention have the formula (1) 1 wherein R 1 , R 2 , U, V, A, B, W, R 3 , C and R 4 have the meaning as defined in the claims.

  本发明涉及联苯和联苯类似化合物，其制备和用作药物组成物，作为整合素拮抗剂，特别是用于制备用于治疗和预防癌症、动脉硬化、再狭窄、骨质疏松等骨溶解性疾病和眼科疾病的药物组成物。本发明的化合物具有式（1）其中R1、R2、U、V、A、B、W、R3、C和R4的含义如权利要求中所定义。
• Titanocene based compound, photosensitive composition, photosensitive transfer sheet and pattern forming method
  申请人：Sugiyama Takekatsu

  公开号：US20070212642A1

  公开（公告）日：2007-09-13

  A titanocene compound having a carbonyl group, and a photosensitive composition whose sensitivity has been enhanced by containing this as a photopolymerization initiator, a photosensitive transfer sheet using said photosensitive composition, and a pattern forming method using said photosensitive transfer sheet are provided.

  提供了一种含有羰基的钛环化合物，以及一种光敏组合物，其中包含该钛环化合物作为光聚合引发剂，已增强其敏感度，使用该光敏组合物的光敏转移膜和使用该光敏转移膜的图案形成方法。
• A method of fabricating dithiafulven geminal dithiolate compounds and their selenium analogs
  申请人：International Business Machines Corporation

  公开号：EP0020896A1

  公开（公告）日：1981-01-07

  The invention is directed to novel heterofulvene geminal dithiolate compounds and their selenium and tellurium analogs having the general formula wherein X is selected from S, Se and Te. R is selected from hydrogen, alkyl, aryl, or together forming a ring of carbon or hetero atoms, cyano and dithiocarbonate groups and R1 is selected from alkali, alkaline earth and transition metals, quaternary ammonium, alkyl, acyl, cyclic and heterocyclic groups, or together forming a ring. The novel method of preparing these compounds involves the reaction of a cis-dicyanotetraheterofulvalene derivative with two equivalents of an organic sulfide, selenide or telluride compound, eventually followed by reacting the reaction product with two equivalents of an organic halogenide. The new compounds are key synthetic intermediates for the preparation of tetrathiafulvalene derivatives and tetraselenafulvalene derivatives which are useful in optical printing of conducting patterns, in electrochromic displays and in high resolution lithography.

  本发明涉及具有通式的新型杂富烯宝石级二硫酸盐化合物及其硒和碲类似物。 其中 X 选自 S、Se 和 Te。R 选自氢、烷基、芳基或由碳原子或杂原子、氰基和二硫代碳酸酯基团共同形成的环，R1 选自碱金属、碱土金属和过渡金属、季铵、烷基、酰基、环状基团和杂环基团或共同形成的环。 制备这些化合物的新方法是将顺式二氰基四杂环戊烯衍生物与两当量的有机硫化物、硒化物或碲化物反应，最后再将反应产物与两当量的有机卤化物反应。这些新化合物是制备四噻富戊二烯衍生物和四硒富戊二烯衍生物的关键合成中间体，可用于导电图案的光学印刷、电致变色显示和高分辨率光刻。